You are here

Personalised medicine should be called 'stratified'

Personalised medicine should be called 'stratified'
17th August 2011

Those working at care homes have been advised to stop using the term 'personalised medicine' when referring to treatment that is stratified.

According to Professor Anna Dominiczak, regius professor of medicine, vice-principal and head of college of Medical, Veterinary and Life Sciences at the University of Glasgow, the term is misleading.

She suggested that patients may think that personalised medicine is treatment that is modified for each individual, when actually it is just broken down into groups suffering different effects of the same disease.

"We want to stratify the population with a given condition by better understanding biomarkers, better understanding of mechanisms to choose the best drug or best modality of treatment for large groups of individuals," Professor Dominiczak explained.

A new drug called rivaroxaban, which was developed during research by the University of Edinburgh and Duke University in North California, was recently found to be effective at cutting stroke risk in patients with an irregular heartbeat as well as being easier to administer.

Find the nearest Barchester care home.